Table 1.
Laboratory data at first admission, during attack and after treatment.
| At the time of hospitalization | During attack | 3 weeks after treatment | |
|---|---|---|---|
| Complete blood count: | |||
| Hemoglobin (12–18 gr/dl) | 9.5 | 6.9 | 11.9 |
| Hematocrit (36–54%) | 27.5 | 18.8 | 33.5 |
| Erythrocyte (3.5–6.0 × 106/mcl) | 2.97 | 2.02 | 3.24 |
| White blood cells (3600–10000/mcl) | 13600 | 9100 | 11200 |
| Neutrophile (37–75%) | 86.3 | 72.0 | 73.7 |
| Lymphocyte (20–55%) | 8.1 | 9.0 | 22.0 |
| Monocyte (2.5–10%) | 1.0 | 4.7 | 2.2 |
| Eosinophil (0.5–11%) | 4.6 | 5.7 | 2.1 |
| Basophil (0–2%) | 0.0 | 8.6 | 0.0 |
| Platelet (150.000–450.000/mcl) | 286.000 | 110.000 | 234.000 |
| Erythrocyte sedimentation rate (0–20 mm) | 33 | 7 | 21 |
| Tryptase (<13.5 ng/mL) | — | >200 | >200 |
| Histamine (<10 nmol/L) | — | >100 | 29.7 |